Earned doctorate (or its foreign equivalent) or appropriate terminal degree. Experience in microbial ecology, molecular methods and/or bioinformatics to…
From Marquette University - Mon, 19 Apr 2021 22:22:29 GMT - View all Milwaukee, WI jobs

Funding Opportunity PAR-21-209 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to recruit Early Stage Investigators (ESI) to pursue research programs of interest to NIH Chemical Countermeasures Research Program (CCRP) under the Countermeasures Against Chemical Threats (CounterACT) grant/cooperative agreement program. ESI CounterACT R21 projects may be exploratory, applied, proof of principle, or high risk-high impact research to discover safe and effective therapeutics to mitigate toxicities resulting from exposures to highly toxic chemicals. A distinct feature for this FOA is that no preliminary data are required, expected, or encouraged. However, if available, minimal preliminary data are allowed. All preliminary data should be clearly marked and limited to one-half page, which may include one figure. Applications including preliminary data more than one-half page or more than one figure will be considered noncompliant with the FOA instructions and will not go forward to review. Projects supported by this FOA will have an extended level of support (3 years) and are expected to generate preliminary data that would facilitate the development of competitive applications for more extensive funding support from the NIH CounterACT programs or other related initiatives.

Funding Opportunity RFA-HD-22-004 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support innovative, multidisciplinary, interactive, and synergistic program projects that integrate basic, translational, and clinical approaches to understanding the developmental biology and genetic basis of significant congenital human malformations. Each program project will consist of three component research projects, in addition to associated cores. At least one project must use basic research in an animal model system and at least one project must be clinical or translational in nature. The component research projects must share a common central theme, focus, or objective on a specific major developmental defect or malformation that is genotypically, mechanistically, biologically, or phenotypically analogous or homologous in both animal models and humans. Any non-mammalian or mammalian animal model may be used, as long as it contributes to the common overall theme or objective of the program project. The component research projects should share a common developmental gene, process, mechanism, pathway, or phenotype.

Notice NOT-HS-21-011 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-MH-21-230 from the NIH Guide for Grants and Contracts. ADHD is a neurodevelopmental disorder with symptoms and impairments that emerge early and persist into adulthood for a substantial portion of affected individuals. While evidence-based treatments exist for school-age children and adolescents with ADHD, findings from longitudinal research suggests that children and adolescents who receive evidence-based interventions for ADHD remain significantly impaired relative to their non-ADHD peers over time. Early identification and intervention for young children with ADHD may be a necessary first step in normalizing symptoms across development and mitigating negative outcomes. The number of preschool children diagnosed with ADHD has been growing in recent years, more than doubling between 2007 and 2016 (Danielson et al., 2017). This increase may be due in part to the 2011 expansion of the American Academy of Pediatrics (AAP) ADHD Clinical Practice Guideline to include recommendations for children as young as 4-years-old (Wolraich et al., 2019). Behavioral interventions are recommended in the AAP Guideline as the first-line treatment for preschoolers with ADHD symptoms, due largely to parental preferences and data suggesting a higher rate of ADHD medication-related side effects and adverse events among younger children. Yet little research has been conducted to test the effectiveness of behavioral interventions in this population. A handful of completed NIMH-funded efficacy studies support the feasibility and promise of conducting interventions research in the preschool ADHD population. However, no preschool ADHD effectiveness trials designed to test service-ready, scalable approaches have been funded by NIMH to date, further highlighting the need for research in this area.

Notice NOT-OD-21-093 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-OD-21-006 from the NIH Guide for Grants and Contracts. The NIH Office of Research on Women's Health (ORWH) and participating NIH Institutes and Centers invite institutional career development award applications for Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Career Development Programs, hereafter termed "Programs". Programs will support mentored research career development of junior faculty members, known as BIRCWH Scholars, who have recently completed clinical training or postdoctoral fellowships, and who will be engaged in interdisciplinary basic, translational, behavioral, clinical, and/or health services research relevant to the health of women and, where appropriate, the use of both sexes to better understand the influence of sex as a biological variable on health and disease.

Funding Opportunity RFA-MH-21-188 from the NIH Guide for Grants and Contracts. The purpose of this R34 FOA is to provide resources for evaluating the feasibility, acceptability, and safety of novel approaches that are uniquely tailored to the risk profiles of these populations, that will improve outcomes and modify health risk behavior. Resources may also be used for obtaining the preliminary data needed as a prerequisite to a larger-scale (efficacy or effectiveness) services study. The goal is to support research that develops and tests broadly implementable service system interventions to rapidly identify and effectively respond to reduce suicide and suicidal behavior in various groups of at-risk youth. Specifically, the goals of this FOA are to: 1) develop a multi-level service system intervention that coordinates suicide risk identification, evaluation, and linkage to needed treatment and services for a specifically identified at-risk youth group; 2) test the feasibility and effectiveness of the intervention in detecting and reducing suicide risk and suicidal behavior in the at-risk youth group; and 3) demonstrate the intervention's implementation and potential for future uptake in underserved, under-resourced community settings where additional at-risk youth are most likely to receive care. The ultimate goal of this FOA is to develop and test the effectiveness of evidence-based strategies for detecting and preventing suicide and suicidal behavior among at-risk youth. It focuses on systems interventions to improve outcomes for youth and is not intended to support the development of new screening tools or assessment instruments.

Funding Opportunity RFA-MH-21-187 from the NIH Guide for Grants and Contracts. The purpose of this R01 FOA is to provide resources for evaluating the feasibility, acceptability, and safety of novel approaches that are uniquely tailored to the risk profiles of these populations, that will improve outcomes and modify health risk behavior. Resources may also be used for obtaining the preliminary data needed as a prerequisite to a larger-scale (efficacy or effectiveness) services study. The goal of the R01 FOA is to support research that develops and tests broadly implementable service system interventions to rapidly identify and effectively respond to reduce suicide and suicidal behavior in various groups of at-risk youth. Specifically, the goals of this FOA are to: 1) develop a multi-level service system intervention that coordinates suicide risk identification, evaluation, and linkage to needed treatment and services for a specifically identified at-risk youth group; 2) test the feasibility and effectiveness of the intervention in detecting and reducing suicide risk and suicidal behavior in the at-risk youth group; and 3) demonstrate the intervention's implementation and potential for future uptake in underserved, under-resourced community settings where additional at-risk youth are most likely to receive care. The ultimate goal of this FOA is to develop and test the effectiveness of evidence-based strategies for detecting and preventing suicide and suicidal behavior among at-risk youth. It focuses on systems interventions to improve outcomes for youth and is not intended to support the development of new screening tools or assessment instruments.

Notice NOT-TW-21-006 from the NIH Guide for Grants and Contracts

Competitive Salary: EMBL: About this position We are looking to recruit an experienced Full Stack developer to join the Literature Services Team at the European Bioinformati Hinxton, Cambridgeshire, England

Notice NOT-OD-21-111 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-230 from the NIH Guide for Grants and Contracts

Notice NOT-AG-21-023 from the NIH Guide for Grants and Contracts

Notice NOT-CA-21-044 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-MH-21-186 from the NIH Guide for Grants and Contracts. This announcement for an R34 FOA solicits pilot studies that develop and test the effectiveness of multi-level systems interventions that predict suicide risk and/or connect. Black youth who are at risk for suicide and suicidal behaviors, to needed treatment and services to prevent suicide. The purpose of the companion R01 FOA is to provide resources for evaluating the feasibility, acceptability, and safety of novel community-based, systems level approaches to improving outcomes, assessing and modifying health risk behavior, and for obtaining the preliminary data needed as a prerequisite to a larger-scale (efficacy or effectiveness) services study. These must incorporate community or stakeholder advisory boards (which include members of the communities served, providers, youth, etc.), to help inform the development of the intervention.

Funding Opportunity RFA-MH-21-185 from the NIH Guide for Grants and Contracts. The announcement would solicit pilot studies that develop and test the effectiveness of multi-level systems interventions that predict suicide risk and/or connect. Black youth who are at risk for suicide and suicidal behaviors, to needed treatment and services to prevent suicide. There would be a companion R01 announcement. The purpose of the R01 FOA is to provide resources for evaluating the feasibility, acceptability, and safety of novel community-based, systems level approaches to improving outcomes, assessing and modifying health risk behavior, and for obtaining the preliminary data needed as a prerequisite to a larger-scale (efficacy or effectiveness) services study. These must incorporate community or stakeholder advisory boards (which include members of the communities served, providers, youth, etc.), to help inform the development of the intervention.

Notice NOT-CA-21-056 from the NIH Guide for Grants and Contracts

Notice NOT-LM-21-007 from the NIH Guide for Grants and Contracts

Notice NOT-OD-21-094 from the NIH Guide for Grants and Contracts